Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.

Prince William and Kate Middleton marked Valentine’s Day by sharing a rare PDA-packed photo of them kissing in what’s believed to be a first for the royal couple. In the adorable snap shared on ...

New cancer treatments are proving effective, but expensive, impacting overall healthcare expenditures. Researcher says reimbursements could be made conditional on reaching endpoints.

The FDA has approved Adcetris (brentuximab vedotin) for use in combination with lenalidomide and rituximab to treat patients with relapsed/refractory LBCL after 2 or more lines of systemic therapy who ...

The human body is teeming with trillions of symbiotic microorganisms, profoundly impacting our well-being. Within the gut, ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

We recently published a list of Jim Cramer Discussed 10 Stocks Leading the Dow Higher in 2025. In this article, we are going ...

For rural patients, getting cancer treatment close to home has always been difficult. But in recent years, chemotherapy ...

One of the most significant challenges in cancer treatment is the development of drug resistance by cancer cells, which often leads to treatment failure. When we say the body "resists" cancer ...

Ovarian Cancer Targeted Medication: PARP Inhibitors, Anti-Angiogenic Drugs, Immunotherapy, and More Ovarian cancer is the malignancy with the highest rate of death from tumors of the female ...

Pfizer has ended development of a B7-H4-directed antibody-drug conjugate (ADC), triggering a $1 billion impairment charge. | ...